Maxim Group Sticks to Their Buy Rating for Silexion Therapeutics (SLXN)

Tip Ranks
2025.10.25 15:55
portai
I'm PortAI, I can summarize articles.

According to TipRanks, Rahman is an analyst with an average return of -10.6% and a 32.93% success rate. Rahman covers the Healthcare sector, focusing on stocks such as Vivani Medical, Silexion Therapeutics, and Cingulate Inc. Silexion Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $24.00.

According to TipRanks, Rahman is an analyst with an average return of -10.6% and a 32.93% success rate. Rahman covers the Healthcare sector, focusing on stocks such as Vivani Medical, Silexion Therapeutics, and Cingulate Inc.

Silexion Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $24.00.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.